Related Articles

Join the VIVA-MIND Study of an Oral Drug for Alzheimer’s!

Researchers at The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio are recruiting participants for the VIVA-MIND study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems.  Volunteers ages 50 to 89 with a diagnosis of mild cognitive impairment or probable mild …
The post Join the VIVA-MIND Study of an Oral Drug for Alzheimer’s! appeared first on Salud America.

Minimize the Impact of COVID-19: Updated Guidance from the CDC

COVID-19 is not over, especially for Latinos. To help people stay vigilant in stopping the spread, the CDC recently published an updated Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems. “To prevent medically significant COVID-19 illness and death, persons must understand their risk, take steps to …
The post Minimize the Impact of COVID-19: Updated Guidance from the CDC appeared first on Salud America.